Press release
Related Press
22 February 2024
CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants
The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....
11 January 2021
Biospectal Announces Public Beta Launch Of OptiBP™
Biospectal’s OptiBP smartphone app and data platform empowers people worldwide with a medical-grade device integrated directly into their smartphone, enabling instantaneous blood pressure measurement ...
3 February 2023
Making personalized cancer therapies accessible to all
CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments. ...